Implantable Bluetooth Pacemaker Streamlines Remote Monitoring
By HospiMedica International staff writers Posted on 24 Jan 2022 |

Image: The Alizea pacemaker with Bluetooth connectivity (Photo courtesy of MicroPort CRM)
A novel pacemaker that pairs to a home monitor provides timely automated alerts and patient triggered warnings when symptomatic.
The MicroPort CRM (Clamart, France) Alizea Bluetooth Pacemaker is cardiac rhythm management (CRM) device with two sensors (an accelerometer and a minute ventilation sensor) that adapt the physiologic response to suit patient activity. The two sensors continually cross-check each other, preventing unnecessary rate increases due to artifacts. Features include SafeR, an AV node management solution that reduces ventricular pacing while managing long PR intervals; SAM, a sleep apnea monitoring tool; and AutoMRI mode, which detects an MRI field and automatically switches to asynchronous mode.
Alizea connects via Bluetooth to SmartView Connect, a home remote monitoring system that offers patient monitoring and follow-up, timely alerts and detailed reports on the patient, removing the need for hospital-based routine examinations and reducing burden on the healthcare system. It also offers customizable alerts, including alerts that oversee system integrity, ensuring the pacemaker’s continuous function; alerts that indicate potential dislodgement or lead fracture; and notifications of post-MRI device function.
“We successfully launched Alizea in Europe in June 2021, and Japan is the second region to benefit from its advanced technological functions,” said Benoît Clinchamps, President of MicroPort CRM, on the occasion of regulatory approval of the Alizea in Japan. “As part of our commitment to improve the lives of as many patients as possible, and to support healthcare professionals in their mission, we will continue to deploy Alizea and Smartview Connect around the world.”
“Around 64,000 patients are implanted with a pacemaker each year in Japan, and coupled with the difficulties that have arisen from the current health crisis, there is a growing need to monitor patients remotely, without them having to travel,” said Noboru Shimizu, VP of MicroPort CRM sales in Japan. “Thanks to Alizea pacemakers and its SmartView Connect monitor, we are positioning ourselves in the Japanese market with the very best in cardiac pacing. I am convinced that this will allow us to strengthen our presence in Japan.”
Within the right atrium of the heart is a natural pacemaker that sends an electrical stimulus that travels from the pacemaker (the SA node) to the ventricles (the AV node). In the presence of an AV block, the transfer of the electrical nerve conduction that regulates the normal, rhythmic, pumping action of the heart muscle is interrupted or slowed.
Related Links:
MicroPort
The MicroPort CRM (Clamart, France) Alizea Bluetooth Pacemaker is cardiac rhythm management (CRM) device with two sensors (an accelerometer and a minute ventilation sensor) that adapt the physiologic response to suit patient activity. The two sensors continually cross-check each other, preventing unnecessary rate increases due to artifacts. Features include SafeR, an AV node management solution that reduces ventricular pacing while managing long PR intervals; SAM, a sleep apnea monitoring tool; and AutoMRI mode, which detects an MRI field and automatically switches to asynchronous mode.
Alizea connects via Bluetooth to SmartView Connect, a home remote monitoring system that offers patient monitoring and follow-up, timely alerts and detailed reports on the patient, removing the need for hospital-based routine examinations and reducing burden on the healthcare system. It also offers customizable alerts, including alerts that oversee system integrity, ensuring the pacemaker’s continuous function; alerts that indicate potential dislodgement or lead fracture; and notifications of post-MRI device function.
“We successfully launched Alizea in Europe in June 2021, and Japan is the second region to benefit from its advanced technological functions,” said Benoît Clinchamps, President of MicroPort CRM, on the occasion of regulatory approval of the Alizea in Japan. “As part of our commitment to improve the lives of as many patients as possible, and to support healthcare professionals in their mission, we will continue to deploy Alizea and Smartview Connect around the world.”
“Around 64,000 patients are implanted with a pacemaker each year in Japan, and coupled with the difficulties that have arisen from the current health crisis, there is a growing need to monitor patients remotely, without them having to travel,” said Noboru Shimizu, VP of MicroPort CRM sales in Japan. “Thanks to Alizea pacemakers and its SmartView Connect monitor, we are positioning ourselves in the Japanese market with the very best in cardiac pacing. I am convinced that this will allow us to strengthen our presence in Japan.”
Within the right atrium of the heart is a natural pacemaker that sends an electrical stimulus that travels from the pacemaker (the SA node) to the ventricles (the AV node). In the presence of an AV block, the transfer of the electrical nerve conduction that regulates the normal, rhythmic, pumping action of the heart muscle is interrupted or slowed.
Related Links:
MicroPort
Latest Critical Care News
- Implantable Device Could Save Diabetes Patients from Dangerously Low Blood Sugar
- New Prostate Screening Device Could Replace Traditional Examination Method
- Adaptive Spine Board to Revolutionize ER Transport
- Mapping Communication Between Internal Organs to Enable Earlier Illness Diagnosis
- Intelligent Wound Dressing Reduces Inflammation and Promotes Healing
- Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
- New Understanding of Barrett’s Esophagus Formation to Enable Earlier Intervention and Diagnosis
- 3D Printed Functional Human Islets Could Transform Type 1 Diabetes Treatment
- AI Model Predicts ICU mortality in Heart Failure Patients
- Smart Capsule Offers Real-Time Profiling Across GI Tract
- Ultra-Thin Implant Helps Patients with Spinal Cord Injury Recover Lost Functions
- Portable Cell Therapy Device to Enable Rapid On-Demand Modification of RBCs at POC
- Monitoring Airborne Fungal Spores Could Help Predict COVID-19 & Flu Surges
- New System Measures Blood Sodium Without Needles
- Sleep Data from Wearable Device May Help Predict Preterm Birth
- AI Tool Interprets Echocardiograms in Minutes
Channels
Surgical Techniques
view channel
Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery
Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more
LED-Based Imaging System Could Transform Cancer Detection in Endoscopy
Gastrointestinal cancers remain one of the most common and challenging forms of cancer to diagnose accurately. Despite the widespread use of endoscopy for screening and diagnosis, the procedure still misses... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more